The Board of Directors Approved the 2022 Q2 Consolidated Financial Statements
· Issued by Microbio Co., Ltd.
Close
Today's Information
Provided by: MICROBIO CO.,LTD.
SEQ_NO
1
Date of announcement
2022/08/12
Time of announcement
17:04:34
Subject
The Board of Directors Approved the 2022 Q2
Consolidated Financial Statements
Date of events
2022/08/12
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/08/12
2.Date of the audit committee approved:2022/08/12
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):885,296
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):362,445
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):(97,776)
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):211,375
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):214,153
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):246,293
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.48
11.Total assets end of the period (thousand NTD):14,858,681
12.Total liabilities end of the period
(thousand NTD):1,093,407
13.Equity attributable to owners of parent end of the
period (thousand NTD):11,811,105
14.Any other matters that need to be specified:None
